Skip to content

Novo Integrated Sciences, Inc.: 10-K filed 2012-04-06

What Novo Integrated Sciences, Inc. reported in its annual report filed 2012-04-06 (fiscal FY 2011): 17 published measures, 60 facts as tagged in accession 0001188112-12-000996.

This filing

Form
10-K (annual report)
Filed
2012-04-06
Fiscal period
fiscal FY 2011
Accession
0001188112-12-000996 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Novo Integrated Sciences, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2011-12-3125,812USD
At 2010-12-311,187,072USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2011-12-312,353,923USD
At 2010-12-312,679,161USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2011-12-31-2,328,111USD
At 2010-12-31-1,492,089USD
At 2009-12-31-885,715USD
At 2008-12-31-1,438,841USD
At 2007-12-31-992,448USD
At 2006-12-31-460,336USD
At 2005-12-31-463,433USD
At 2004-12-31-305,082USD
At 2003-12-31-217,977USD
At 2002-12-31-184,786USD
At 2001-12-3116,982USD
At 2000-12-315,971USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-2,238,011USD365
2000-11-28 to 2011-12-31-16,371,158USD4051
2010-01-01 to 2010-12-31-2,569,223USD365
2008-01-01 to 2008-12-31-982,677USD366
2007-01-01 to 2007-12-31-2,470,352USD365
2006-01-01 to 2006-12-31-1,465,077USD365
2005-01-01 to 2005-12-31-1,068,738USD365
2004-01-01 to 2004-12-31-282,009USD366
2003-01-01 to 2003-12-31-190,567USD365
2002-01-01 to 2002-12-31-2,796,768USD365
2001-01-01 to 2001-12-31-31,789USD365
2000-11-28 to 2000-12-31-4,029USD34

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2011-01-01 to 2011-12-3152,412,362shares365
2000-11-28 to 2011-12-3120,477,687shares4051
2010-01-01 to 2010-12-3143,256,282shares365

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2011-01-01 to 2011-12-31-0.04USD/shares365
2000-11-28 to 2011-12-31-0.8USD/shares4051
2010-01-01 to 2010-12-31-0.06USD/shares365

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2011-12-317,056USD
At 2010-12-317,285USD

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2011-12-3118,756USD
At 2010-12-31237,155USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2011-12-31141,089USD
At 2010-12-311,082,134USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2011-12-31116,290USD
At 2010-12-31162,281USD

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2011-01-01 to 2011-12-31146,779USD365
2000-11-28 to 2011-12-313,882,494USD4051
2010-01-01 to 2010-12-31208,565USD365

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2011-12-3156,503,946shares
At 2010-12-3145,844,161shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

PeriodValueUnitDays
At 2011-12-3114,277,622USD
At 2010-12-3112,526,812USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

PeriodValueUnitDays
At 2011-12-3147,863USD
At 2010-12-3144,025USD

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2011-01-01 to 2011-12-313,838USD365
2000-11-28 to 2011-12-3150,946USD4051
2010-01-01 to 2010-12-314,837USD365

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2011-01-01 to 2011-12-31241,320USD365
2000-11-28 to 2011-12-313,877,793USD4051
2010-01-01 to 2010-12-31930,936USD365

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2011-01-01 to 2011-12-3172,722USD365
2000-11-28 to 2011-12-31325,128USD4051
2010-01-01 to 2010-12-3177,886USD365

Inspect the source

Entity
Novo Integrated Sciences, Inc. / CIK 0001138978
Captured
2026-09-21T17:18:44.141Z
SEC response SHA-256
2c05b67386a7c51ae2db3b1f04bcf71f64bf887526ff32a3b714db1dcc2aff05

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001138978.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))